Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group (Q70238308)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336986%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336986%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group (English)

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

1 October 2023

author name string

D. R. Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336986

1 October 2023

S. Leikin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336986

1 October 2023

V. Albo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336986

1 October 2023

H. Sather

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336986

1 October 2023

M. Karon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336986

1 October 2023

D. Hammond

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336986

1 October 2023

language of work or name

English

0 references

publication date

1 March 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336986%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

15 March 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6336986

full work available at URL

1 October 2023

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819830315%2951%3A6%3C1041%3A%3AAID-CNCR2820510612%3E3.0.CO%3B2-G

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6336986

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

1 October 2023

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

1 October 2023

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

1 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336986%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336986%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336986%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

1041-1049

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336986%20AND%20SRC:MED&resulttype=core&format=json

Additive therapy in the maintenance of remission in acute lymphoblastic leukemia of childhood: the effect of the initial leukocyte count

9 October 2019

cites work

1

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970

1 October 2023

3

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Factors that influence haematological remission duration in acute lymphocytic leukaemia

1 October 2023

4

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 October 2023

5

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

1 October 2023

Cancer Treatment Reports

6

64

199

Miller

1980

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL)

1 October 2023

7

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 October 2023

11

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

A Reappraisal of the Results of Stopping Therapy in Childhood Leukemia

1 October 2023

14

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: a report from Childrens Cancer Study Group

1 October 2023

15

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol)

1 October 2023

16

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens

1 October 2023

17

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Childhood acute lymphocytic leukemia. Study VIII

1 October 2023

18

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program

1 October 2023

22

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Acute lymphoblastic leukemia: Treatment

1 October 2023

24

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

1 October 2023

Journal of Immunology

26

123

1312

Reinherz

1979

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Cytogenetic studies in acute lymphocytic leukemia: special emphasis in long-term survival

1 October 2023

27

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Differences in prognosis for boys and girls with acute lymphoblastic leukaemia

1 October 2023

28

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Combined modality therapy of acute lymphocytic leukemia

1 October 2023

29

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment patient characteristics and treatment. A report for Childrens Cancer Study Group

1 October 2023

30

1 reference

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1041::AID-CNCR2820510612%3E3.0.CO;2-G

1 October 2023

Identifiers

10.1002/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6336986%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference